Drug Development Support Services
Transferra specializes in manufacturing drug-carrier nanoparticle complexes and lipid nanoparticle formulations. As per FDA’s draft guidance on liposomal drug production, product performance is assessed using a diverse set of physical-chemical measurements such as particle size distribution, in-vitro release analysis, encapsulation versus free drug quantitation, and drug to carrier ratio determination. These measurements allow the development and optimization of new formulations with specific pharmaceutical performance characteristics.
Transferra offers analytical tech transfer, assay development, method qualification/validation and routinely provides cGMP release and ICH stability testing on products consisting of conventional small molecules, peptides, proteins, lipids, carbohydrates, and oligonucleotides. Transferra has the chemistry expertise and equipment for the analysis of these types of new drug formulations.